Aortic stenosis ... ECG findings of left ventricular hypertrophy with strain and left atrial enlargement are non-specific. Two-dimensional echocardiography can demonstrate a thickened aortic valve ...

The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies.

In patients greater than age 65, more than 90% of aortic stenosis involves trileaflet valves which have developed heavy calcification. [5] In these instances the calcium deposits are thought to ...

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

Researchers from the University of Sheffield and the University of East Anglia have implemented a cutting-edge 4D flow MRI ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aortic stenosis without ...

DAVID MONTGOMERY: Aortic stenosis is a tightening of one of the four major valves of the heart. The aortic valve is particularly important because the aortic valve is the gateway to the rest of ...

Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...

Surgery to replace an aortic valve is done for aortic valve stenosis and aortic valve regurgitation ... and a physical therapist to make these changes. This is sometimes called cardiac rehabilitation.

University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before.